Literature DB >> 7806387

Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases.

V M Gordon1, K R Klimpel, N Arora, M A Henderson, S H Leppla.   

Abstract

Before intoxication can occur, anthrax toxin protective antigen (PA), Pseudomonas exotoxin A (PE), and diphtheria toxin (DT) must be activated by proteolytic cleavage at specific amino acid sequences. Previously, it was shown that PA and DT can be activated by furin. In Chinese hamster ovary (CHO) cells, wild-type (RKKR) and cleavage site mutants of PA, each administered with a modified form of anthrax toxin lethal factor (the N terminus of lethal factor fused to PE domain III), had the following potencies: RKKR (wild type) (concentration causing 50% cell death [EC50] = 12 ng/ml) > or = RAAR (EC50 = 18 ng/ml) > FTKR (EC50 = 24 ng/ml) > STRR (EC50 = 49 ng/ml). In vitro cleavage of PA and cleavage site mutants of PA by furin demonstrated that native PA (RKKR) and PA with the cleavage sequence RAAR are substrates for furin. To characterize eukaryotic proteases that play a role in activating bacterial toxins, furin-deficient CHO cells were selected after chemical mutagenesis. Furin-deficient cells were resistant to PE, whose cleavage site, RQPR, constitutes a furin recognition site and to all PA cleavage site mutants, but were sensitive to DT (EC50 = 2.9 ng/ml) and PA (EC50 = 23 ng/ml), whose respective cleavage sites, RKKR and RVRR, contain additional basic residues. Furin-deficient cells that were transfected with the furin gene regained sensitivity to PE and PA cleavage site mutants. These studies provide evidence that furin can activate the three toxins and that one or more additional proteases contribute to the activation of DT and PA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7806387      PMCID: PMC172960          DOI: 10.1128/iai.63.1.82-87.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  39 in total

1.  Proprotein processing activity and cleavage site selectivity of the Kex2-like endoprotease PACE4.

Authors:  J W Creemers; P J Groot Kormelink; A J Roebroek; K Nakayama; W J Van de Ven
Journal:  FEBS Lett       Date:  1993-12-20       Impact factor: 4.124

2.  Role of beta-turn in proteolytic processing of peptide hormone precursors at dibasic sites.

Authors:  N Brakch; M Rholam; H Boussetta; P Cohen
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

Review 3.  Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases.

Authors:  V M Gordon; S H Leppla
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

4.  A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1.

Authors:  Y Ohnishi; T Shioda; K Nakayama; S Iwata; B Gotoh; M Hamaguchi; Y Nagai
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  PACE4 is a member of the mammalian propeptidase family that has overlapping but not identical substrate specificity to PACE.

Authors:  A Rehemtulla; P J Barr; C J Rhodes; R J Kaufman
Journal:  Biochemistry       Date:  1993-11-02       Impact factor: 3.162

6.  Positional and additive effects of basic amino acids on processing of precursor proteins within the constitutive secretory pathway.

Authors:  T Watanabe; K Murakami; K Nakayama
Journal:  FEBS Lett       Date:  1993-04-12       Impact factor: 4.124

7.  Evidence for involvement of furin in cleavage and activation of diphtheria toxin.

Authors:  M Tsuneoka; K Nakayama; K Hatsuzawa; M Komada; N Kitamura; E Mekada
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

8.  Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells.

Authors:  N Arora; K R Klimpel; Y Singh; S H Leppla
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.486

9.  Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL.

Authors:  S Seetharam; V K Chaudhary; D FitzGerald; I Pastan
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.486

10.  Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands.

Authors:  T E Willnow; J Herz
Journal:  J Cell Sci       Date:  1994-03       Impact factor: 5.235

View more
  119 in total

1.  Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Authors:  Sherry R Crowe; Linda L Ash; Renata J M Engler; Jimmy D Ballard; John B Harley; A Darise Farris; Judith A James
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor.

Authors:  Vibha Chauhan; Rakesh Bhatnagar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  Characterization of dominant-negative forms of anthrax protective antigen.

Authors:  Ming Yan; R John Collier
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

Review 4.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

5.  Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays.

Authors:  Rebecca A Brady; Anita Verma; Bruce D Meade; Drusilla L Burns
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

6.  Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.

Authors:  Sherry R Crowe; Lori Garman; Renata J M Engler; A Darise Farris; Jimmy D Ballard; John B Harley; Judith A James
Journal:  Vaccine       Date:  2011-03-21       Impact factor: 3.641

7.  A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.

Authors:  Patricia M Day; Yuk-Ying S Pang; Rhonda C Kines; Cynthia D Thompson; Douglas R Lowy; John T Schiller
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

Review 8.  Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins.

Authors:  Rodney K Tweten
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

9.  The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases.

Authors:  Nadia Nour; Gaétan Mayer; John S Mort; Alexandre Salvas; Majambu Mbikay; Charlotte J Morrison; Christopher M Overall; Nabil G Seidah
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

10.  A key interaction between the alphavirus envelope proteins responsible for initial dimer dissociation during fusion.

Authors:  Whitney Fields; Margaret Kielian
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.